NeuroOne Medical Technologies Corporation

We are committed to providing minimally invasive and hi-definition electrodes for recording, stimulation and therapeutic solutions for neurological conditions

[NeuroOne Medical Technologies Corporation @N1MTC]

Precision over systemic exposure. Dr. Sandipan Pati of the @UMNews on the case for targeted brain drug delivery — the goal behind @N1MTC's work in this space.

[NeuroOne Medical Technologies Corporation @N1MTC]

Trigeminal neuralgia is one of the most debilitating pain conditions that patients face. The OneRF® Trigeminal Nerve Ablation System gives surgeons a precise, minimally invasive option to treat facial pain. Learn more: https://t.co/Uob738earB

(Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

@n1mtc has received ISO 13485:2016 certification, the international quality management standard for medical devices, achieved ahead of schedule. Full release here: https://t.co/Cldx30zXxo (Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC has launched official investor relations channels on @Stocktwits, @YahooFinance, and @X to establish a dedicated space for transparent updates and open dialogue with our investor community.

Yahoo Finance: @NeuroOne_IR
X: @NeuroOne_IR
Stocktwits: @NeuroOne_IR

[MZ North America @MZ_NorthAmerica]

NeuroOne® Achieves Major Milestone With ISO 13485 Certification
https://t.co/8XOLD3HJS0

$NMTC #NeuroOne #OneRF® @N1MTC
https://t.co/hWxq0RhT0v

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC's pipeline reflects our commitment to expanding treatment options for patients with neurological disorders. Take a closer look at what we are building next. https://t.co/qJ8Vt8s94Z

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC is excited to launch our new Products in Development page on our website. Get a peek into the technologies of the future that we hope will redefine treatments and patient care. https://t.co/qJ8Vt8s94Z

[NeuroOne Medical Technologies Corporation @N1MTC]

Our work is driven by the patients we serve. https://t.co/q9GPQ0VvKz

[NeuroOne Medical Technologies Corporation @N1MTC]

"We call it brain, pain, and drug delivery." — @N1MTC CEO Dave Rosa

In case you missed it, Dave joined @adamsarhan of Smart Money Circle to talk about the technology behind those three words — and what's ahead for NeuroOne.

https://t.co/Vd24Rt1a6c

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC CEO Dave Rosa joined @adamsarhan of Smart Money Circle Show to talk about what NeuroOne is building — and why it matters for patients with epilepsy, trigeminal neuralgia, and chronic pain.  (Caution: RxOnly) https://t.co/eaPXZY0hSi

[NeuroOne Medical Technologies Corporation @N1MTC]

Congratulations to our team member Aura Kullmann for presenting her research at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting! Thank you, Aura, for representing @N1MTC at AANS and advancing the science behind our platform. (Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC is excited to present at the American Society of Gene & Cell Therapy 2026 Annual Meeting, May 11-15 in Boston, MA. Join us at booth 1400 to learn about our sEEG-Drug Delivery System (CED with Neural Recording & Stimulation Capability).

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC is proud to highlight the scientific and clinical posters related to the OneRF® Ablation System and other NeuroOne products in development. These will be presented at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting. (Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

@N1MTC is excited to present at the American Association of Neurological Surgeons (AANS) 2026 Annual Meeting — May 1–4 at the Henry B. González Convention Center in San Antonio, Texas. We'll be there alongside our strategic partner @zimmerbiomet. (Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

Our commitment to advancing epilepsy care drives everything we do. https://t.co/q9GPQ0VvKz

[NeuroOne Medical Technologies Corporation @N1MTC]

Parkinson's disease affects tens of thousands each year—impacting patients, families, and healthcare systems. At @N1MTC, we're transforming neurological care through minimally invasive technologies. Awareness is the first step. Innovation drives the rest.

[NeuroOne Medical Technologies Corporation @N1MTC]

Advancing epilepsy care starts with precision. Our Evo® sEEG electrodes provide high-definition recording of brain activity for patients undergoing epilepsy evaluation. Precise seizure localization is critical for determining the best treatment path. (Caution: RxOnly)

[NeuroOne Medical Technologies Corporation @N1MTC]

Today is Purple Day—a global movement to raise epilepsy awareness. At @N1MTC, advancing care for the epilepsy community is at the heart of our mission. We stand with patients, caregivers, and medical professionals driving progress.

[NeuroOne Medical Technologies Corporation @N1MTC]

Join us for a virtual investor webinar on Thursday, March 12, 2026 at 11:30 a.m. ET. Management will provide a corporate update, discuss our growth plans, and share updates on our platform technologies and commercialization efforts. https://t.co/iweXaMcMRX

[MZ North America @MZ_NorthAmerica]

NeuroOne® to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 AM ET
https://t.co/YLdVK5fkiS

Dial-In: 888-506-0062
Int'l: 973-528-0011
Access Code: 358063
Webcast: https://t.co/tkODJqOkB2

$NMTC #NeuroOne #OneRF® @N1MTC
https://t.co/hWxq0RhT0v